This article examines the comparative cost of generic medicines and their impact on healthcare expenditures. An analysis of the economic efficiency of generic drugs compared with original (brand-name) medicines was conducted. Particular attention is given to the factors influencing the formation of drug prices and the economic accessibility of medicines for the population.

The study highlights the advantages of using generic medicines as an important tool for reducing pharmacotherapy costs. The analysis demonstrates that generic medicines, having proven bioequivalence to original drugs, can provide a similar therapeutic effect at a significantly lower cost. This contributes to the optimization of financial resources within the healthcare system and improves the accessibility of medical treatment for a wider population.

 The results of the study confirm that the rational use of generic medicines is an important direction for improving the economic efficiency of pharmaceutical provision. The broader use of generic medicines helps reduce healthcare expenditures and ensures more efficient allocation of budgetary resources without compromising the quality of medical care.

generic medicines, original drugs, drug costs, pharmacoeconomics, healthcare expenditures, drug accessibility, price analysis, pharmaceutical supply, rational pharmacotherapy, economic efficiency.

World Health Organization (2020). Generic medicines – key facts. https://www.who.int

European Medicines Agency (2021). Generic medicines guidance. https://www.ema.europa.eu

OECD (2021). Pharmaceutical spending and policies. https://www.oecd.org

Министерство здравоохранения Республики Узбекистан. https://lex.uz

Xidoyatova Z.Sh., Islomova Sh.S., Tohirjonov J.J. GPP (zarur dorixona amaliyoti) standartining dorixona muassasalari faoliyatiga tadbiq etilishini o`rganish//International journal of scientific researchers, Volume15,issue2, р.507-514

Suyunov, N. D., & Rajabova, N. X. (2023). Performance indicators of the medicines used in squamous cell lung cancer. Farmaciya (Pharmacy), 72(1), 36-48.

Хидоятова З.Ш., Шаякубова Л. А., Азимова М. Т. Генерические препараты: роль и значение в современной фармацевтике //журнал Фармация, №2 2026, стр 23-33

Суюнов, Н. Д., Ражабова, Н. Х. (2021). Ўпка саратони касаллигини даволашда қўлланиладиган дори воситаларининг ассортимент таҳлили. Фармацевтический журнал, 1(4), 5-17.

Суюнов, Н. Д., Ражабова, Н. Х. (2022). Ўпка саратони билан касалланган беморларнинг тиббий карталари ретроспектив таҳлили. Фармацевтический журнал, 1(6), 21-30.